We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
Cap. Flow
-$39M
Cap. Flow %
-8.97%
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$4.08M
2
UI icon
Ubiquiti
UI
+$3.96M
3
CRM icon
Salesforce
CRM
+$3.69M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.57M
5
GMED icon
Globus Medical
GMED
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Technology 17.18%
3 Consumer Discretionary 15.3%
4 Financials 9.77%
5 Consumer Staples 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
276
Humana
HUM
$46.4B
-10,500
Closed -$1.82M
ICFI icon
277
ICF International
ICFI
$1.56B
-10,500
Closed -$686K
IDCC icon
278
InterDigital
IDCC
$8.41B
-6,300
Closed -$1.9M
IHS icon
279
IHS Holding
IHS
$2.85B
-105,000
Closed -$864K
IMCR icon
280
Immunocore
IMCR
$1.65B
-63,000
Closed -$1.9M
INSP icon
281
Inspire Medical Systems
INSP
$2.12B
-10,500
Closed -$542K
IRTC icon
282
iRhythm Holdings
IRTC
$3.69B
-29,400
Closed -$3.47M
KHC icon
283
The Kraft Heinz Company
KHC
$29.4B
-42,000
Closed -$945K
KNSA icon
284
Kiniksa Pharmaceuticals
KNSA
$6.13B
-21,000
Closed -$1.01M
KSS icon
285
Kohl's
KSS
$1.91B
-210,000
Closed -$2.71M
LEN icon
286
Lennar Class A
LEN
$18.9B
-10,500
Closed -$912K
LYFT icon
287
Lyft
LYFT
$5.83B
-210,000
Closed -$2.79M
MDB icon
288
MongoDB
MDB
$32B
-10,500
Closed -$2.57M
MNDY icon
289
monday.com
MNDY
$3.83B
-10,500
Closed -$726K
MOS icon
290
The Mosaic Company
MOS
$8.09B
-84,000
Closed -$2.14M
MPC icon
291
Marathon Petroleum
MPC
$118B
-4,200
Closed -$1.03M
MSM icon
292
MSC Industrial Direct
MSM
$6.81B
-10,500
Closed -$969K
NOMD icon
293
Nomad Foods
NOMD
$1.53B
-168,000
Closed -$1.61M
NUTX
294
Nutex Health
NUTX
$1.51B
-21,000
Closed -$2M
NUVB icon
295
Nuvation Bio
NUVB
$2.15B
-105,000
Closed -$450K
NVAX icon
296
Novavax
NVAX
$1.67B
-42,000
Closed -$342K
PATH icon
297
UiPath
PATH
$7.18B
-210,000
Closed -$2.33M
PAX icon
298
Patria Investments
PAX
$1.63B
-84,000
Closed -$1.06M
PAYC icon
299
Paycom
PAYC
$10.3B
-16,800
Closed -$2.04M
PGNY icon
300
Progyny
PGNY
$2.08B
-210,000
Closed -$3.57M

Similar funds

Hussman Strategic Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.

  • Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
  • Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
  • Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
  • Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
  • Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
  • Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
  • Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.